The 5 Best Dividend Stocks In Cholesterol Drugs

There's good news, bad news, and more good news about high cholesterol levels. The first good news is that the percentage of Americans with high cholesterol is falling. The bad news is that over 73 million Americans still have high "bad" cholesterol levels.What's the other piece of good news? Several of the top companies that make the drugs that have helped reduce cholesterol levels offer really attractive dividends.Amgen (NASDAQ: AMGN), AstraZeneca (NYSE: AZN), Novartis (NYSE: NVS), Pfizer (NYSE: PFE), and Sanofi (NYSE: SNY) all compete in the cholesterol-drug market.

Topics:  americans   amgen nasdaq   amgn    astrazeneca nyse   azn    novartis nyse   nvs    pfizer nyse   pfe    sanofi nyse   sny    dividend   cholesterol   drugs   news   good   high   bad   levels   

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News